Item added to cart
I. Pathological Basis of Therapy in Alzheimers Disease.- Criteria for the Diagnosis of Alzheimers Disease.- Criteria for the Clinical Diagnosis of Alzheimers Disease: Transcultural Aspects.- Clinical And Neuropathological Findings from Cerad.- Differentiating Alzheimer Disease and Vascular Dementia: Reframing the Question.- Neuropathology Of Alzheimers Disease.- Basis of Structural Alzheimer Disease and Some Pathogenic Concepts.- Regional Distribution of Neuropathological Changes in Alzheimers Disease.- Alzheimer Neurofibrillary Degeneration: A Feasible and Key Target for Therapeutics.- Diabetes and Dementia: A Retrospective Neuropathologic Study of Old Diabetics Compared to Non-Diabetic Controls.- Processing of Amyloid, Cytoskeletal Damage and Apolipoproteins.- Isoform-Specific Metabolism of Apolipoprotein E: Implications for Alzheimers Disease.- Apolipoprotein E4 and Cholinergic Activity in Alzheimers Disease.- A New Focus on Cytoskeletal Therapy in Alzheimers Disease.- Novel Cathepsin D Inhibitors Prevent the ?-Secretase-Derived Intracellular Formation of a 12 kDA Potentially Amyloidogenic Product in Human Cells.- Cellular and Test Tube Models of Amyloid-? Formation.- Effects of ?-Amyloid (140) Peptide Injection in the Nucleus Basalis.- ?Amyloid Precursor Protein Role in Cognitive Brain Function?.- Peptides Inhibitor of Amyloidogenesis in Alzheimers Disease.- Cell Death: Excitotoxins, Apoptosis And Hypometabolism.- Apoptosis and Alzheimers Disease: A Self-Assembly and the Initiation of Apoptosis by Plasma Membrane Receptor Cross-Linking.- NMDA Receptor Dysfunction in Alzheimers Disease.- Role of Neuron-Glia Interactions in Brain Energy Metabolism: Implications for Neurodegenerative Disorders.- Neurotrophins, Growth Factors and Neuroprotectors.- Neurotrophins, Growth Factors and Mimetic Agents as Neuroprotectors in the Treatment of Alzheimers Disease.- Cortical Synaptogenesis and Behavioural Consequences in CNS Lesioned Animals Receiving Neurotrophilƒ*
Copyright © 2018 - 2024 ShopSpell